Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) significantly improve prostate cancer detection at initial biopsy in a total PSA range of 2-10 ng/ml.

Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) significantly improve prostate cancer detection at initial biopsy in a total PSA range of 2-10 ng/ml.

Many efforts to reduce prostate specific antigen (PSA) overdiagnosis and overtreatment have been made. To this aim, Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) have been proposed as new more specific biomarkers. We evaluated the ability of phi and PCA3 to identify prostate cance...

Full description

Bibliographic Details
Main Authors: Matteo Ferro, Dario Bruzzese, Sisto Perdonà, Ada Marino, Claudia Mazzarella, Giuseppe Perruolo, Vittoria D'Esposito, Vincenzo Cosimato, Carlo Buonerba, Giuseppe Di Lorenzo, Gennaro Musi, Ottavio De Cobelli, Felix K Chun, Daniela Terracciano
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3701535?pdf=render

Internet

http://europepmc.org/articles/PMC3701535?pdf=render

Similar Items